The Phase II trial examined the therapeutic cancer vaccine Tedopi in combination with chemotherapy drug combination FOLFIRI.

PDAC is an aggressive malignancy that originates in the pancreatic ducts and accounts for approximately 95% of all pancreatic cancers. The global incidence of pancreatic cancer has more than doubled ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

Pancreatic cancer, the ultimate master of disguise, often sneaks in without a grand entrance—until it is already made itself at home. From surprise weight loss to unexpected digestive drama, here are ...